B. Y. Azizeh

发表

Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A beta peptide.

C. Cotman, F. LaFerla, D. Cribbs, 2000, Biochemistry.

Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to Alzheimer’ β amyloid peptide

C. Cotman, F. LaFerla, D. Cribbs, 2000 .

Cross-linking of NCAM receptors on neurons induces programmed cell death

C. Cotman, B. Y. Azizeh, D. Cribbs, 1998, Brain Research.

Structure-activity studies of hydrophobic amino acid replacements at positions 9, 11 and 16 of glucagon.

V. Hruby, D. Trivedi, B. Y. Azizeh, 2009, The journal of peptide research : official journal of the American Peptide Society.

Structure-function studies on positions 17, 18, and 21 replacement analogues of glucagon: the importance of charged residues and salt bridges in glucagon biological activity.

S. Burley, V. Hruby, J. Krstenansky, 1998, Journal of medicinal chemistry.

Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists.

V. Hruby, M. Houslay, B. V. Van Tine, 1996, Endocrinology.

[des His1, des Phe6, Glu9]glucagon amide: A newly designed “pure” glucagon antagonist

V. Hruby, B. V. Tine, D. Trivedi, 1995 .

Low Level Cyclic Adenosine 3',5'-Monophosphate Accumulation Analysis of (des-His',des-

V. Hruby, M. Houslay, B. V. Tine, 1996 .

The role of phenylalanine at position 6 in glucagon's mechanism of biological action: multiple replacement analogues of glucagon.

V. Hruby, D. Trivedi, B. Y. Azizeh, 1997, Journal of medicinal chemistry.

5. Molecular dating of senile plaques in the brains of individuals with Down syndrome.

C. Cotman, E. Head, R. Torp, 2000 .

Complement Association with Neurons and β-Amyloid Deposition in the Brains of Aged Individuals with Down Syndrome

C. Cotman, E. Head, D. Cribbs, 2001, Neurobiology of Disease.

Molecular Dating of Senile Plaques in the Brains of Individuals with Down Syndrome and in Aged Dogs

C. Cotman, E. Head, R. Kim, 2000, Experimental Neurology.

Pure Glucagon Antagonists: Biological Activities and cAMP Accumulation Using Phosphodiesterase Inhibitors

V. Hruby, B. V. Tine, D. Trivedi, 1997, Peptides.

Asymmetric amino acid substitution at the Tyr10 position of glucagon leads to greater binding differences

V. Hruby, B. V. Tine, D. Trivedi, 1995 .